ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Small Cell Lung Carcinoma
Cancer
Colorectal Cancer
Neoplasm Metastasis
Breast Cancer
Squamous Cell Carcinoma of Head and Neck

Lung Cancer trials near Chicago, IL, USA:

Personalizing Veterans' Lung Cancer Screening and Diagnosis (MAS-EXPAND)

Lung cancer screening with low-dose chest computed tomography (CT) is currently recommended for high-risk individuals who are 50 to...

Invitation-only
Lung Cancer Screening
Cancer Survivor
Procedure: Low-dose computed tomography
VA Office of Research and Development
VA Office of Research and Development

Chicago, Illinois, United States and 6 other locations

Evaluate FlowPath Lung Diagnostic Test of Sputum Samples to Detect the Presence of Lung Cancer in High-risk Individuals Wh...

Enrolling
Lung Cancer (Diagnosis)
Other: Standard medical treatment
bioAffinity Technologies

North Chicago, Illinois, United States and 10 other locations

Locations recently updated

when given alone or with chemotherapy . Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or s ...

Enrolling
Lung Neoplasms
Small Cell Lung Cancer ( SCLC )
Drug: Chemotherapy
Drug: PF-08634404

Phase 2

Pfizer
Pfizer

Hinsdale, Illinois, United States and 60 other locations

This research study aims to investigate methods for enhancing lung cancer screening. The study will investigate whether an artifici ...

Enrolling
Lung Cancer Screening
Diagnostic Test: Sybil Artificial Intelligence (AI) screening
University of Illinois
University of Illinois

Chicago, Illinois, United States and 1 other location

Inhibitor( TKI) , to recurrent, advanced, or metastatic small cell lung cancer (SCLC) patients , Non-Small Cell Lung (NSCL...

Enrolling
Small Cell Lung Cancer
Non-Small Cell Lung
Drug: AL8326 40 mg
Drug: AL8326 60 mg

Phase 2

Advenchen

Chicago, Illinois, United States and 6 other locations

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Chicago, Illinois, United States and 72 other locations

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Docetaxel
Drug: DS-1062a

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Chicago, Illinois, United States and 210 other locations

The primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.

Enrolling
Extensive Stage Small Cell Lung Cancer
Drug: Tarlatamab

Phase 1

Amgen
Amgen

Chicago, Illinois, United States and 31 other locations

combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...

Active, not recruiting
Limited Stage Small Cell Lung Cancer
Drug: Durvalumab
Drug: BMS-986489

Phase 2

SCRI Development Innovations

Arlington Heights, Illinois, United States and 33 other locations

This is a phase II trial of adjuvant chemotherapy and immunotherapy for completely resected small cell lung cancer (SCLC)....

Enrolling
Small Cell Lung Cancer (SCLC)
Drug: Durvalumab 50 MG/ML

Phase 2

Alliance Foundation Trials

Chicago, Illinois, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems